14-DAY TAILORED PCR-GUIDED TRIPLE THERAPY VERSUS 14-DAY NON-BISMUTH CONCOMITANT QUADRUPLE THERAPY FOR HELICOBACTER PYLORI ERADICATION: A MULTICENTER, OPEN-LABEL RANDOMIZED CONTROLLED TRIAL, THE HEPYSE TRIAL

Aurelien Amiot  1     Jeremy Hacoon  2     Frederic Heluwaert  3     Francois Mion  4     Dominique Lamarque  5     Driffa Moussata  6     Jean-Charles Delchier  2     Etienne Audureau  2     Sylvie Bastuji-Garin  2    
1 Henri Mondor Hospital, APHP, Creteil, France
2 Henri Mondor University Hospital, Creteil, France
3 Annecy General Hospital, Annecy, France
4 Hospices Civils de Lyon, Lyon, France
5 Versailles University- Ambroise Pare, Boulogne Billancourt, France
6 Lyon Sud Hospital Gastroenterology GETAID Group, Pierre BĂ©nite, France

Topic
Stomach & H. Pylori

Conference
UEG Week 2023

Citation
United European Gastroenterology Journal 2023; 11 (Supplement 8)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Social Sharing